跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 105,082 条关于
“Group 2 Pulmonary Hypertension”
全部
105,082
临床试验
76,077
药物
7,839
机构
1,898
资讯
19,268
去年
Gradient's Pulmonary Artery Denervation System Receives FDA Breakthrough Designation for Pulmonary Hypertension
去年
Gradient Denervation Technologies Expands Pulmonary Hypertension Trial and Appoints Stanton Rowe to Board
去年
Tectonic's TX45 Shows Promise in Phase 1b Trial for Pulmonary Hypertension with HFpEF
去年
Tectonic Therapeutic's TX45 Shows Promise in Phase Ia Trial for Pulmonary Hypertension
26天前
Pulnovo Medical Enrolls First U.S. Patients in PULSE-LHD IDE Trial of PADN for Pulmonary Hypertension Associated with Left Heart Disease
7个月前
Pulmovant Completes Enrollment in Phase 2 Trial of Mosliciguat for Pulmonary Hypertension Associated with Interstitial Lung Disease
去年
Pulnovo Medical Secures $100M Series C Funding to Advance Pulmonary Hypertension Treatment
去年
Corteria Pharmaceuticals Advances First-in-Class CRF2 Agonists into Phase 2 Heart Failure and Phase 1 Obesity Trials
去年
Pulnovo Medical Raises $100M to Advance Pulmonary Hypertension Treatment Development
去年
Liquidia Secures $100M Financing to Advance Yutrepia for Pulmonary Hypertension Treatment
第 1 页,共 1927 页
上一页
下一页